During the active phase of the experiment (conducted for 2 months), patients from group A received tamsulosin 0.4 mg/day once and solifenacin at a double dose of 20 mg/day once, patients from group B received tamsulosin 0.4 mg/day and solifenacin in a standard dose of 10 mg/day once, patients from group C received a placebo.
The text above was approved for publishing by the original author.
只需要到您的收件箱，点击我们的确认链接，您将得到正确的信息。如果您希望更正更多的电子邮件，只需要简单的：
或